Clinical trial

Combination Chemotherapy Followed by Surgery in Treating Patients With Stomach…

NCT00004103 · NYU Langone Health, Other · Completed

Key facts

NCT number NCT00004103
Title Combination Chemotherapy Followed by Surgery in Treating Patients With Stomach Cancer
Official title A Phase II Study of Systemic Therapy With CPT-11 (Camptosar HCl) and Cisplatin in Patients With Advanced Gastric Cancer to be Followed by Surgical Resection and Postoperative Intraperitoneal Chemotherapy
Lead sponsor NYU Langone Health, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 2
Study type Interventional
Conditions Gastric Cancer
Intervention type Drug, Procedure
Interventions cisplatin, floxuridine, irinotecan hydrochloride, adjuvant therapy, conventional surgery, neoadjuvant therapy
Start date Jul 1, 1998
Primary completion Mar 1, 2007
Completion Jun 1, 2009
First posted Jan 27, 2003
Last update posted Apr 6, 2011
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies